Pharmacokinetic comparison of two recombinant human granulocyte colony-stimulating factor after subcutaneous administration in rabbits

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 61, Issue 3, 2005, Pages 142-148

  Ducongé, Jorge ^a,d   Rodríguez Vera, Leyanis ^a   Valenzuela, Carmen ^b   Álvarez, Daniel ^a   Ramírez, Omar ^a   De La Luz Hernández, Kathya R ^c   Rabeza Legón, Estela Y ^c   Casacó, Ángel ^c   Fernández Sánchez, Eduardo ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^d University of Turabo   (United States)

Author keywords

Clearance; Pharmacokinetics; Recombinant human granulocyte colony stimulating factor

Indexed keywords

LEUKOCIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG FORMULATION; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; RABBIT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ANIMALS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MULTIVARIATE ANALYSIS; RABBITS;

EID: 26444551700     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.06.003     Document Type: Article

References (37)

1. N.A. Nicola, D. Metclaf, M. Matsumoto, and G.R. Johnson Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor J. Biol. Chem. 258 1983 9017 9023
2. D. Metcalf, and N.A. Nicola Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells J. Cell Physiol. 116 1983 198 206
3. K. Welte, E. Platzer, L. Lu, J. Gabrilove, E. Levi, R. Mertelsmann, and M.A.S. Moore Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor Proc. Natl. Acad. Sci. USA 82 1985 1526 1530
4. L.M. Souza, T.C. Boone, J. Gabrilove, P.H. Lai, K.M. Zsebo, D.C. Murdock, V.R. Chazin, J. Bruszewski, H. Lu, K.K. Chen, J. Barendt, E. Platzer, M.A.S. Moore, R. Mertelsmann, and K. Welte Recombinant human G-CSF: effects on normal and leukemic myeloid cells Science (Washington DC) 232 1986 61 65
5. S. Nagata, M. Tsuchiya, S. Asano, Y. Kaziro, T. Yamazaki, O. Yamamoto, Y. Hirata, N. Kubota, M. Oheda, H. Nombra, and M. Ono Molecular cloning and expression of cDNA for human G-CSF Nature (Lond.) 319 1986 415 418
6. M. Tsuchiya, S. Asano, Y. Kaziro, and S. Nagata Isolation and characterization of the cDNA for murine G-CSF Proc. Natl. Acad. Sci. USA 83 1986 7633 7637
7. Z. Podja, G. Molineux, and T.M. Dexter Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF Exp. Hematol. 18 1990 27 31
8. A.M. Cohen, K.M. Zsebo, H. Inoue, D. Hines, T.C. Boone, V.R. Chazin, L. Tsai, T. Ritch, and L.M. Souza In vivo stimulation of granulopoiesis by recombinant human G-CSF Proc. Nat. Acad. Sci. USA 84 1987 2484 2488
9. H. Tanaka, Y. Okada, M. Kawagishi, and T. Tokiwa Pharmacokinetics and pharmacodynamics of recombinant human G-CSF after intravenous and subcutaneous administration in the rat J. Pharmacol. Exp. Ther. 251 1989 1199 1203
10. K. Welte, A.M. Bonilla, A.P. Gillio, T.C. Boone, G.K. Potter, J.L. Gabrilove, M.A.S. Moore, R.J. O'Reilly, and L.M. Souza Recombinant human G-CSF. Effects on hematopoiesis in normal and cyclophosphamide-treated primates J. Exp. Med. 165 1987 941 948
11. M.H. Bronchud, J.H. Scarffe, N. Thatcher, D. Crowther, L.M. Souza, N.K. Alton, N.G. Testa, and T.M. Dexter Phase I/II study of recombinant human G-CSF in patients receiving intensive chemotherapy for small cell lung cancer Br. J. Cancer 56 1987 809 813
12. G. Morstyn, L. Campbell, L.M. Souza, N.K. Alton, J. Keech, M. Green, W. Sheridan, D. Metclaf, and R. Fox Effect of G-CSF on neutropenia indiced by cytotoxic chemotherapy Lancet 1 1988 667 672
13. H. Teshima, J. Isikawa, H. Kitayama, T. Yamagami, A. Hiraoka, H. Nakamura, H. Shibata, T. Masaoka, and F. Takaku Clinical effects of rhG-CSF in leukemia patients: a phase I/II study Exp. Hematol. 17 1989 853 858
14. S. Nagata M.B. Sporn A.B. Roberts Peptide growth factors and their receptors 1990 Springer New York, USA 190
15. S. Nagata A. Thompson The cytokine handbook 2nd ed 1994 Academic Press New York, USA 371
16. J.L. Gabrilove Clinical applications of granulocyte colony stimulating factor (G-CSF) Growth Factors 6 1992 187 191
17. FDA Guidance Concerning Demonstration of Comparability of Human Biological Products, including Therapeutic Biotechnology-derived Products, July 1996, CBER, Rockville, MD, USA, http://www.fda.gov/cder/compare.htm, revised April 2003.
18. E.T. Polastro, A.D. Little, The future of biogenerics: When will we see legal generics of top biopharmaceuticals?, http://www.contractpharma.com/oct013. htm, revised November 2003.
19. Catalog DCS50, Quantikine Human G-CSF Immunoassay, For the quantitative determination of human granulocyte colony stimulating factor concentrations in cell culture supernate, serum and plasma, available at http://www.rndsystems. com, revised April 2003.
20. J.G. Wagner, and E. Nelson Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drugs J. Pharm. Sci. 53 1964 1392 1403
21. J. Läuter Exact t- and F-tests for analyzing studies with multiple endpoints Biometrics 52 1996 964 970
22. J. Läuter, E. Glimm, and S. Kropf New multivariate test for data with an inherent structure Biometrical J 38 1996 5 23
23. M. Okabe, M. Asano, T. Kuga, Y. Komatsu, M. Yamasaki, Y. Yokoo, S. Itoh, M. Morimoto, and T. Oka In vitro and in vivo hematopoietic effect of mutant human granulocyte colony stimulating factor Blood 75 9 1990 1788 1793
24. X.W. Liu, and Z.M. Tang Pharmacokinetic of recombinant human granulocyte colony stimulating factor in rabbits and mice Zhongguo Yao Li Xue Bao 18 1 1997 44 48
25. Product Information. F Hoffman-La Roche SA, Basilea, Switzerland, 1998.
26. ® Inc. Thousand Oaks, California, 91320-1789, 1994.
27. H. Tanaka, and T. Tokiwa Pharmacokinetics of recombinant human G-CSF studied in the rat by a sandwich enzyme-linked immunosorbent assay J. Pharmacol. Exp. Ther. 255 1990 724 729
28. H. Tanaka, and T. Kaneko Pharmacokinetics of recombinant human G-CSF in mice Blood 79 2 1992 536 539
29. N. Hayashi, H. Aso, M. Higashida, H. Kinoshita, S. Ohdo, E. Yukawa, and S. Higuchi Estimation of rhG-CSF absorption kinetics after subcutaneous administration using a modified Wagner-Nelson method with a nonlinear elimination model Eur. J. Pharm. Sci. 13 2001 151 158
30. Y. Kato, T. Seita, T. Kuwabara, and Y. Sugiyama Kinetic analysis of receptor-mediated endocytosis (RME) of proteins and peptides: Use of RME as a drug delivery system J. Controlled Release 39 1996 191 200
31. W. Strober, and T.A. Waldmann The role of the kidney in the metabolism of plasma proteins Nephron 13 1974 35 66
32. T. Maack, V. Johnson, S.T. Kau, J. Figneiredo, and D. Sigulem Renal filtration, transport and metabolism of low-molecular weight proteins: a review Kidney Int. 16 1979 251 270
33. T. Kuwabara, T. Uchimura, H. Kobayashi, S. Kobayashi, and Y. Sugiyama Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow Am. J. Physiol. (Endocrinol. Metab.) 269 1995 E1 E9
34. T. Kuwabara, Y. Kato, S. Kobayashi, H. Suzuki, and Y. Sugiyama Nonlinear pharmacokinetics of a colony-stimulating factor derivative (nartograstim). Species differences among rats, monkeys and humans J. Pharmacol. Exp. Ther. 271 1994 1535 1543
35. A.C. Houston, L.A. Stevens, and V. Cour Pharmacokinetics of glycosylated recombinant human G-CSF (lenograstim) in healthy male volunteers Br. J. Clin. Pharmacol. 47 1999 279 284
36. T. Kuwabara, S. Kobayashi, and Y. Sugiyama Kinetic analysis of receptor-mediated endocytosis of G-CSF derivative, nartograstim, in rat bone marrow cells Am. J. Physiol. 271 1996 E73 E84
37. R.L. Zeid Regulatory and development issues in the demonstration of therapeutic equivalence for multisource biotech-derived pharmaceuticals Drug Information J 34 2000 919 959